Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Propofol, Sevoflurane, and Isoflurane on Oxygen Transport in Cardiac Surgery
NCT05693428Completed
- Sponsor
- Astana Medical University
- Start
- Jan 2022
- Primary completion
- Nov 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Randomised, open-label trial of sevoflurane and isoflurane in coronary heart disease (CHD) (3 arms), sponsored by Astana Medical University. Primary endpoints: Cardiac Index at 1 year, Oxygen Transport at 1 year and 2 more. Started Jan 2022; status: completed.
02
Drugs
sevofluraneisoflurane
03
Conditions
coronary heart disease (CHD)
Beyond the preview
Go deeper on NCT05693428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05693428.